Print this page    •   Back to Web version of article

HCV 101: Prevalence of Hepatitis C Virus in the United States

June 2004

The following table is adapted from the Centers for Disease Control and Prevention's HCV Web-based training course "Hepatitis C: What Clinicians and Other Health Professionals Need to Know." The text is based upon the Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-related Chronic Disease (Centers for Disease Control and Prevention. MMWR 1998; 47 [No. RR-19]).

Table 1. Estimated Average Prevalence of Hepatitis C Virus (HCV) Infection in the United States by Various Characteristics and Estimated Prevalence of Persons With These Characteristics in the Population
 HCV-Infection PrevalencePrevalence of Persons With Characteristic, %
%(range, %) 
Persons with hemophilia treated with products made before 198787(74-90)<0.01
Injecting drug users
   history of prior use

No Data


Persons with abnormal alanine aminotransferase levels15(10-18)5
Chronic hemodialysis patients10(0-64)0.1
Persons with multiple
sex partners (lifetime)



Persons reporting a history of sexually transmitted diseases6(1-10)17
Persons receiving blood transfusions before 19906(5-9)6
Infants born to infected mothers5(0-25)0.1
Men who have sex with men4(2-18)5
General population1.8(1.5-2.3)NA*
Healthcare workers1(1-2)9
Pregnant women1--1.5
Military personnel0.3(0.2-0.4)0.5
Volunteer blood donors0.16--5
* Not applicable

This article was provided by Brown Medical School. It is a part of the publication HEPP Report. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.